Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MPIF advances to phase II trials in cancer patients

Nov. 19, 1998

First potent, orally active LHRH antagonist discovered by Takeda

Nov. 19, 1998

U.S. patent protects methods of angiogenesis inhibition using Xoma's BPI products

Nov. 19, 1998

FDA advisory committee issues positive statement on DepoCyt

Nov. 18, 1998

Novel MMP inhibitor synthesized at Abbott shows potent antitumor activity in vivo

Nov. 18, 1998

Nolvadex now available for breast cancer prevention

Nov. 17, 1998

Teijin's new vitamin D derivatives induce cell differentiation

Nov. 17, 1998

IntraBiotics initiates phase II clinical trial for oral mucositis treatment

Nov. 17, 1998

SU-101 may be indicated for combination therapy of prostate cancer

Nov. 17, 1998

Grape-derived polyphenol inhibits HepG2 cell invasion in vitro; shows potential in HCC

Nov. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...